RELAPSED SMALL CELL LUNG CANCER

Clinical trials for RELAPSED SMALL CELL LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new RELAPSED SMALL CELL LUNG CANCER trials appear

Sign up with your email to follow new studies for RELAPSED SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for Tough-to-Treat lung cancer: major trial tests promising drug combinations

Disease control Ongoing

This large, late-stage trial is comparing two experimental treatment approaches against standard chemotherapy for people whose small cell lung cancer has returned after initial treatment. About 705 patients will receive either a new drug called lurbinectedin alone, lurbinectedin …

Matched conditions: RELAPSED SMALL CELL LUNG CANCER

Phase: PHASE3 • Sponsor: PharmaMar • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

RELAPSED SMALL CELL LUNG CANCER

Get alerted when new RELAPSED SMALL CELL LUNG CANCER trials appear

New hope for Tough-to-Treat lung cancer: major trial tests promising drug combinations